Neptune Wellness Solutions Inc Revenue per Employee (NEPT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Neptune Wellness Solutions Inc   (NASDAQ: NEPT)
 

Neptune Wellness Solutions Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Neptune Wellness Solutions Inc 's Revenue per employee fell on a trailing twelve month basis to $ 460,174, but the productivity of Neptune Wellness Solutions Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 54 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 578, from total ranking in previous quarter at 2000. Neptune Wellness Solutions Inc has 85 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEPT Revenue per Employee (Dec 31 2023)
III. Quarter		 (Sep 30 2023)
II. Quarter		 (Jun 30 2023)
I. Quarter		 (Mar 31 2023)
IV. Quarter		 (Dec 31 2022)
III. Quarter
Y / Y Revenue Change -37.75 % -27.09 % -34.69 % 5.34 % -16.76 %
Sales per Employee (TTM) $ 460,174 514,400 552,599 619,004 611,765
NEPT's Total Ranking # 578 # 2000 # 2145 # 2179 # 1163
Seq. Revenue Change -13.05 % -17.76 % -12.51 % -0.5 % 1.85 %

NEPT Company Profile >> Back to NEPT Efficiency Comparisons >> Compare NEPT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 24
Healthcare Sector # 55
Overall Market # 578

Revenue per Employee Statistics
High Average Low
$ 479,388 $ 213,281 $ 0
(Sep 30 2022)   (Mar 31 2018)



Financial Statements
Neptune Wellness Solutions Inc 's Revenue MRQ $ 8 Millions Visit NEPT's Income Statement
Neptune Wellness Solutions Inc 's Revenues TTM $ 39 Millions Visit NEPT's aggregate revenue growth
What are NEPT's Sales? Visit NEPT's Sales by Segment




Other Ratios
Neptune Wellness Solutions Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NEPT's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NEPT's Competitors
Revenue per Employee for NEPT's Suppliers
Revenue per Employee for NEPT's Customers

You may also want to know
NEPT's Sales Growth Rates NEPT's Pe Price to earnings ratio NEPT's Receivables Turnover Ratio NEPT's Stock Quote
NEPT's Net Income Growth Rates NEPT's Ps Price to Sales ratio NEPT's Sales per Employee NEPT's Asset Turnover Ratio
NEPT's Net Margin NEPT's Pb Price to Book ratio NEPT's Financial Strength Ratios NEPT's Dividend Payout Ratio
Date modified: 2026-08-31T07:36:24+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2023Number of Employees Dec 31 2023
Merck and Co Inc   801,533.33 $ 60,115.000  Million 75,000 
Genmab A  789,039.29 $ 2,390.000  Million 3,029 
Pfizer Inc  779,946.67 $ 58,496.000  Million 75,000 
Amicus Therapeutics inc   779,444.23 $ 398.296  Million 511 
Biocryst Pharmaceuticals Inc   761,866.67 $ 331.412  Million 435 
Veru Inc   759,943.00 $ 15.199  Million 20 
Caremax Inc   751,102.00 $ 751.102  Million 1,000 
Biomarin Pharmaceutical Inc  751,079.17 $ 2,419.226  Million 3,221 
Beam Therapeutics Inc   739,156.56 $ 377.709  Million 511 
Kiniksa Pharmaceuticals International Plc  738,412.57 $ 270.259  Million 366 
Galapagos Nv  735,591.45 $ 268.491  Million 365 
Alnylam Pharmaceuticals Inc   731,316.80 $ 1,828.292  Million 2,500 
Hookipa Pharma inc   718,892.86 $ 20.129  Million 28 
Precision Biosciences Inc  716,573.53 $ 48.727  Million 68 
Cidara Therapeutics Inc   714,579.71 $ 49.306  Million 69 
Eton Pharmaceuticals Inc   705,931.82 $ 31.061  Million 44 
Elite Pharmaceuticals Inc   705,850.31 $ 45.880  Million 65 
Ati Physical Therapy Inc   699,016.00 $ 699.016  Million 1,000 
Endo International Plc  686,290.69 $ 2,011.518  Million 2,931 
Eli Lilly And Company  682,482.00 $ 34,124.100  Million 50,000 
Opus Genetics Inc   680,321.43 $ 19.049  Million 28 
Rigel Pharmaceuticals Inc  671,735.63 $ 116.882  Million 174 
Xencor Inc  671,596.15 $ 174.615  Million 260 
Maravai Lifesciences Holdings Inc   664,241.38 $ 288.945  Million 435 
Corcept Therapeutics Inc  660,787.67 $ 482.375  Million 730 
Johnson and Johnson  660,667.61 $ 93,022.000  Million 140,800 
Cardiff Lexington Corporation  658,514.78 $ 11.853  Million 18 
Milestone Scientific Inc   652,840.80 $ 9.793  Million 15 
Quantum Biopharma Ltd   650,829.29 $ 4.556  Million 7 
Skinhealth Systems Inc   647,818.92 $ 397.113  Million 613 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.